This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03916/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB03916/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03916/identifier/pubchem-substance/
n11http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03916/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/resource/drugbank/property/
n5http://linked.opendata.cz/resource/drugbank/drug/DB03916/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03916
rdf:type
n8:Drug
n8:group
experimental
owl:sameAs
n7:DB03916 n11:DB03916
dcterms:title
4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine
adms:identifier
n4:656967 n5:571203 n10:DB03916 n13:46505237 n14:WAI
n8:IUPAC-Name
n9:271B4F6F-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B4F75-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B4F74-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B4F71-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B4F72-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B4F73-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B4F6D-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B4F6B-363D-11E5-9242-09173F13E4C5 n9:271B4F6E-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B4F6C-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B4F7B-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B4F7C-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B4F76-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B4F77-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B4F79-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B4F78-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B4F7A-363D-11E5-9242-09173F13E4C5
n8:Bioavailability
n9:271B4F81-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B4F83-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B4F84-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B4F80-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B4F7F-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B4F82-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B4F70-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B4F7D-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B4F7E-363D-11E5-9242-09173F13E4C5